Guanfacine Tablet, Extended Release
Product Images NDC 72888-224

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 72888-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Guanfacine Er Tabs 1mg 1000s Bottle Label)

Label for Guanfacine Extended-Release Tablets USP, 1 mg strength, oral tablet form. The label indicates packaging of 1000 tablets. Distributed by Advagen Pharma Ltd., East Windsor, NJ, USA, and manufactured by Rubicon Research Pvt. Ltd., India. Includes storage instructions and a barcode area marked FPO.*

FDA Label Image

Image Description (Guanfacine Er Tabs 1mg 100s Bottle Label)

Label for Guanfacine Extended-Release Tablets USP 1 mg, containing 100 tablets. The label shows storage instructions, dosage advice to refer to the package insert, and a warning not to crush, chew, or break tablets before swallowing. Distributed by Advagen Pharma Ltd., manufactured by Rubicon Research Ltd., India. Includes the NDC 72888-224-01 and a barcode.*

FDA Label Image

Image Description (Guanfacine Er Tabs 1mg 30s Bottle Label)

Label for Guanfacine Extended-Release Tablets USP 1 mg, oral dosage form, in a 30 tablet package. Distributed by Advagen Pharma Ltd., East Windsor, NJ, manufactured by Rubicon Research Pvt. Ltd., India. The label includes storage instructions, a barcode, and a note that tablets should not be crushed or chewed before swallowing.*

FDA Label Image

Image Description (Guanfacine Er Tabs 1mg 500s Bottle Label)

Label for Guanfacine Extended-Release Tablets USP 1 mg, oral dosage form, containing 500 tablets. The label indicates storage instructions, warnings against crushing or chewing tablets, and directs to the package insert for dosage information. Distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd.*

FDA Label Image

Image Description (Guanfacine Er Tabs 2mg 1000s Bottle Label)

Packaging label for Guanfacine Extended-Release Tablets, USP 2 mg by Advagen Pharma Limited. The label shows the product name, strength, dosage form, quantity of 1000 tablets, and manufacturer Rubicon Research Pvt. Ltd. Storage instructions and a website for package insert information are also visible.*

FDA Label Image

Image Description (Guanfacine Er Tabs 2mg 100s Bottle Label)

Label for Guanfacine Extended-Release Tablets, USP 2 mg, oral tablet strength. The label shows a 100 tablet package distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Ltd. It includes storage instructions, dosage cautions, and a barcode. The label indicates prescription-only status and provides a website for patient information.*

FDA Label Image

Image Description (Guanfacine Er Tabs 2mg 30s Bottle Label)

Label for Guanfacine Extended-Release Tablets USP 2 mg by Advagen Pharma Limited. The package contains 30 tablets in extended-release oral dosage form. It includes storage instructions (20°C to 25°C), warnings against crushing or chewing tablets, and manufacturer details (Rubicon Research Pvt. Ltd., India).*

FDA Label Image

Image Description (Guanfacine Er Tabs 2mg 500s Bottle Label)

Label for Guanfacine Extended-Release Tablets, USP 2 mg by Advagen Pharma Limited. The oral tablet packaging contains 500 tablets. It includes storage instructions, dosage warnings, manufacturer details (Rubicon Research Pvt. Ltd., India), distributor information (Advagen Pharma Ltd., USA), and a bar code area marked FPO.*

FDA Label Image

Image Description (Guanfacine Er Tabs 3mg 1000s Bottle Label)

Label for Guanfacine Extended-Release Tablets, USP, 3 mg strength. The oral tablet product is supplied by Advagen Pharma Limited, with a package size of 1000 tablets. The label includes storage instructions, the NDC 72888-226-00, and distributor and manufacturer details: Advagen Pharma Ltd. (East Windsor, NJ, USA) and Rubicon Research Pvt. Ltd. (Thane, India).*

FDA Label Image

Image Description (Guanfacine Er Tabs 3mg 100s Bottle Label)

Label for Guanfacine Extended-Release Tablets USP 3 mg, oral tablets in a package of 100. Distributed by Advagen Pharma Limited, manufactured by Rubicon Research Ltd., India. The label includes storage instructions, usage warnings, and a website link for patient information.*

FDA Label Image

Image Description (Guanfacine Er Tabs 3mg 30s Bottle Label)

Label for Guanfacine Extended-Release Tablets USP, 3 mg strength. The oral extended-release tablets are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Pvt. Ltd. The label includes dosage, storage instructions, package insert URL, and regulatory information. Package contains 30 tablets.*

FDA Label Image

Image Description (Guanfacine Er Tabs 3mg 500s Bottle Label)

Label for Guanfacine Extended-Release Tablets, USP 3 mg, oral tablet form, with a package size of 500 tablets. The label lists Advagen Pharma Limited as the distributor and Rubicon Research Pvt. Ltd. as the manufacturer. Storage instructions and warnings about not crushing or chewing tablets are included. The NDC is 72888-226-05.*

FDA Label Image

Image Description (Guanfacine Er Tabs 4mg 1000s Bottle Label)

Label for Guanfacine Extended-Release Tablets, USP 4 mg, a human prescription drug in extended-release tablet form. The label indicates a package size of 1000 tablets and includes storage instructions and manufacturer details. Distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd., India.*

FDA Label Image

Image Description (Guanfacine Er Tabs 4mg 100s Bottle Label)

Label for Guanfacine Extended-Release Tablets, USP 4 mg, oral dosage form. The label indicates a 100-tablet package with NDC 72888-227-01. Distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Ltd. Storage instructions, dosage advice, and patient information sheet URL are also visible. The label includes caution that tablets should not be crushed, chewed, or broken before swallowing.*

FDA Label Image

Image Description (Guanfacine Er Tabs 4mg 30s Bottle Label)

Guanfacine Extended-Release Tablets, USP 4 mg oral tablets packaging label showing 30 tablets per bottle. Distributed by Advagen Pharma Ltd., East Windsor, NJ, and manufactured by Rubicon Research Pvt. Ltd., India. Label includes storage instructions, dosage form, barcode area marked as FPO, and a note that tablets should not be crushed, chewed, or broken before swallowing.*

FDA Label Image

Image Description (Guanfacine Er Tabs 4mg 500s Bottle Label)

Label for Guanfacine Extended-Release Tablets, USP 4 mg, 500 count. Distributed by Advagen Pharma Ltd. and manufactured by Rubicon Research Pvt. Ltd. The label includes storage instructions, a warning not to crush, chew, or break tablets, and directs to the package insert online. The NDC is 72888-227-05.*

FDA Label Image

Image Description (Guanfacine Er Tabs Graph 1)

A pharmacokinetic graph showing plasma concentration of guanfacine (ng/mL) over 24 hours. It compares extended-release guanfacine 1 mg QD with immediate-release guanfacine 1 mg QD, illustrating concentration levels from 0 to 24 hours post-dose.*

FDA Label Image

Image Description (Guanfacine Er Tabs Graph 2)

A fold change and 90% confidence interval chart showing the effect of various CYP3A4/5 inhibitors and inducers and oral medications on pharmacokinetic parameters Cmax and AUC. Included substances are Ketoconazole, Fluconazole, Rifampin, Efavirenz, Oral Methylphenidate, and Lisdexamfetamine Dimesylate, with data from human studies and computer simulations indicating changes relative to a reference.*

FDA Label Image

Image Description (Guanfacine Er Tabs Graph 3)

A pharmacokinetic (PK) fold change graph showing the relative changes in Cmax and AUC with 90% confidence intervals for two interacting drugs, Oral Methylphenidate and Lisdexamfetamine Dimesylate, compared to a reference value of 1.0. The horizontal axis represents change relative to reference, ranging from 0.0 to 2.0.*

FDA Label Image

Image Description (Guanfacine Er Tabs Graph 4)

A line graph depicting treatment failure percentage over time in days, comparing Placebo (solid line) with SPD503 (dashed line). The x-axis represents time to treatment failure up to 203 days, and the y-axis shows treatment failure percentage up to 100%. The graph illustrates differences in treatment failure rates between the two groups over time.*

FDA Label Image

Image Description (Guanfacine Er Tabs Structure)

Chemical structure of guanfacine hydrochloride showing its molecular framework with chlorines on the aromatic ring and the guanidine group. This structure visually represents the active ingredient guanfacine in its hydrochloride form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.